416 related articles for article (PubMed ID: 33241418)
21. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
[TBL] [Abstract][Full Text] [Related]
22. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
23.
Buscarlet M; Provost S; Zada YF; Barhdadi A; Bourgoin V; Lépine G; Mollica L; Szuber N; Dubé MP; Busque L
Blood; 2017 Aug; 130(6):753-762. PubMed ID: 28655780
[TBL] [Abstract][Full Text] [Related]
24. Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia.
Aref S; Sallam N; Abd Elaziz S; Salama O; Al Ashwah S; Ayed M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4299-4305. PubMed ID: 36580013
[TBL] [Abstract][Full Text] [Related]
25. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
26. Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.
Liang DC; Liu HC; Yang CP; Jaing TH; Hung IJ; Yeh TC; Chen SH; Hou JY; Huang YJ; Shih YS; Huang YH; Lin TH; Shih LY
Blood; 2013 Apr; 121(15):2988-95. PubMed ID: 23365461
[TBL] [Abstract][Full Text] [Related]
27. Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML.
Narayanan D; Pozdnyakova O; Hasserjian RP; Patel SS; Weinberg OK
Blood Adv; 2021 Jun; 5(11):2539-2549. PubMed ID: 34100902
[TBL] [Abstract][Full Text] [Related]
28. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis.
Saiki R; Momozawa Y; Nannya Y; Nakagawa MM; Ochi Y; Yoshizato T; Terao C; Kuroda Y; Shiraishi Y; Chiba K; Tanaka H; Niida A; Imoto S; Matsuda K; Morisaki T; Murakami Y; Kamatani Y; Matsuda S; Kubo M; Miyano S; Makishima H; Ogawa S
Nat Med; 2021 Jul; 27(7):1239-1249. PubMed ID: 34239136
[TBL] [Abstract][Full Text] [Related]
29. Clonal Hematopoiesis Has Prognostic Value in Dilated Cardiomyopathy Independent of Age and Clone Size.
Sikking MA; Stroeks SLVM; Henkens MTHM; Raafs AG; Cossins B; van Deuren RC; Steehouwer M; Riksen NP; van den Wijngaard A; Brunner HG; Hoischen A; Verdonschot JAJ; Heymans SRB
JACC Heart Fail; 2024 May; 12(5):905-914. PubMed ID: 37638520
[TBL] [Abstract][Full Text] [Related]
30. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
Cobo I; Tanaka TN; Chandra Mangalhara K; Lana A; Yeang C; Han C; Schlachetzki J; Challcombe J; Fixsen BR; Sakai M; Li RZ; Fields H; Mokry M; Tsai RG; Bejar R; Prange K; de Winther M; Shadel GS; Glass CK
Immunity; 2022 Aug; 55(8):1386-1401.e10. PubMed ID: 35931086
[TBL] [Abstract][Full Text] [Related]
31. Lineage restriction analyses in CHIP indicate myeloid bias for
Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of clonal hematopoiesis in VEXAS syndrome.
Gutierrez-Rodrigues F; Kusne Y; Fernandez J; Lasho T; Shalhoub R; Ma X; Alessi H; Finke C; Koster MJ; Mangaonkar A; Warrington KJ; Begna K; Xie Z; Ombrello AK; Viswanatha D; Ferrada M; Wilson L; Go R; Kourelis T; Reichard K; Olteanu H; Darden I; Hironaka D; Alemu L; Kajigaya S; Rosenzweig S; Calado RT; Groarke EM; Kastner DL; Calvo KR; Wu CO; Grayson PC; Young NS; Beck DB; Patel BA; Patnaik MM
Blood; 2023 Jul; 142(3):244-259. PubMed ID: 37084382
[TBL] [Abstract][Full Text] [Related]
33. Association of clonal haematopoiesis with severe postoperative complications in patients undergoing radical oesophagectomy.
Wang H; Yan H; Chen W; Tang H; Pei Y; Shan Q; Cang J; Miao C; Tan L; Tan L
Br J Anaesth; 2024 Feb; 132(2):277-284. PubMed ID: 38044238
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.
Aslanyan MG; Kroeze LI; Langemeijer SM; Koorenhof-Scheele TN; Massop M; van Hoogen P; Stevens-Linders E; van de Locht LT; Tönnissen E; van der Heijden A; da Silva-Coelho P; Cilloni D; Saglio G; Marie JP; Tang R; Labar B; Amadori S; Muus P; Willemze R; Marijt EW; de Witte T; van der Reijden BA; Suciu S; Jansen JH
Ann Hematol; 2014 Aug; 93(8):1401-12. PubMed ID: 24994606
[TBL] [Abstract][Full Text] [Related]
35. Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR.
Mas-Peiro S; Pergola G; Berkowitsch A; Meggendorfer M; Rieger MA; Vasa-Nicotera M; Dimmeler S; Zeiher AM
Clin Res Cardiol; 2023 May; 112(5):585-593. PubMed ID: 36680616
[TBL] [Abstract][Full Text] [Related]
36. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
Jaiswal S; Libby P
Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
[TBL] [Abstract][Full Text] [Related]
37. TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract][Full Text] [Related]
38. CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease.
Hecker JS; Hartmann L; Rivière J; Buck MC; van der Garde M; Rothenberg-Thurley M; Fischer L; Winter S; Ksienzyk B; Ziemann F; Solovey M; Rauner M; Tsourdi E; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Paulus AC; Lützner J; Roth A; Bassermann F; Spiekermann K; Marr C; Hofbauer LC; Platzbecker U; Metzeler KH; Götze KS
Blood; 2021 Nov; 138(18):1727-1732. PubMed ID: 34139005
[TBL] [Abstract][Full Text] [Related]
39. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.
Traina F; Visconte V; Jankowska AM; Makishima H; O'Keefe CL; Elson P; Han Y; Hsieh FH; Sekeres MA; Mali RS; Kalaycio M; Lichtin AE; Advani AS; Duong HK; Copelan E; Kapur R; Olalla Saad ST; Maciejewski JP; Tiu RV
PLoS One; 2012; 7(8):e43090. PubMed ID: 22905207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
